Evidence map›Paper›PMID 26174777›Full record

ArticlePediatric blood & cancer2015

Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012.

Charlotte Baker, Althea M Grant, Mary G George, Scott D Grosse, Thomas V Adamkiewicz

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Advances in the Diagnosis and Treatment of Pediatric Arterial Ischemic Stroke.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Risk Factors of Pediatric Arterial Ischemic Stroke; A Regional Survey.International journal of preventive medicine · 2018
    Article
  10. Article
  11. Sickle Cell Disease and Stroke: Diagnosis and Management.Current neurology and neuroscience reports · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Charlotte BakerDivision of Blood Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Althea M GrantDivision of Blood Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mary G GeorgeDivision for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Scott D GrosseDivision of Blood Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Thomas V AdamkiewiczDepartment of Family Medicine, Morehouse School of Medicine, Atlanta, Georgia.
Centers for Disease Control and Prevention · USMorehouse School of Medicine · USNational Center for Chronic Disease Prevention and Health Promotion · USNational Center on Birth Defects and Developmental Disabilities · US

Funding

Training/Education CoreP20MD003383 · NIMHD · AUGUSTA UNIVERSITY · PI IKUTA, TOHRU · 2009 to 2013
$6.8M
Intramural CDC HHS CC999999NIMHD NIH HHS 1P20MD003383-01NIMHD NIH HHS P20 MD003383
6 · The paper itself

Abstract

backgroundApproximately 10-20% of children with sickle cell disease (SCD) develop stroke, but few consistent national estimates of the stroke burden for children with SCD exist. The purpose of this study is to determine the proportion of diagnosed stroke among African-American pediatric discharges with and without SCD. PROCEDURE: Records for African-Americans aged 1-18 years in the Kids' Inpatient Database (KID) 1997-2012 with ≥1 ICD-9-CM diagnosis code for stroke were included. Data were weighted to provide national estimates. A total of 2,994 stroke cases among African-American children were identified. Diagnoses co-existing with ischemic or hemorrhagic stroke were frequency ranked separately.

resultsFrom 1997 through 2012, SCD was present in 24% of stroke discharges, with 89% being ischemic stroke. For hospital discharges of African-American children, SCD is the highest co-existing risk factor for ischemic stroke (29%). Stroke in children with SCD occurred predominantly in children aged 5-9 years, older than previously reported. The trend of stroke discharges significantly decreased for children with SCD from 1997 to 2012 for children aged 10-14 years.

conclusionsSCD is a leading risk factor to pediatric stroke in African-American children. Reducing the number of strokes among children with SCD would have a significant impact on the rate of strokes among African-American children. Preventative intervention may be modifying initial age of presentation of stroke in children with SCD.

Indexed as

Black or African AmericanDatabases, FactualAdolescentAnemia, Sickle CellBrain IschemiaChildChild, PreschoolFemaleHumansInfantMalePatient DischargeRetrospective StudiesStrokeUnited Stateshemorrhagic strokehospitalizationischemic strokesickle cell disease

Identifiers

PMID26174777
PMCPMC4624016
OpenAlexW1549417429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.